Skip to main content

Personalized Biological Therapies

  • Chapter
  • First Online:
Textbook of Personalized Medicine
  • 1377 Accesses

Abstract

Historically blood transfusion and organ transplantation were the first personalized therapies as they were matched to the individuals. Some cell therapies that use the patient’s own cells are considered to be personalized medicines particularly vaccines prepared from the individual patient’s tumor cells. More recently recombinant human proteins have been used to provide individualization of therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Dhiman N, Ovsyannikova IG, Vierkant RA et al (2008) Associations between SNPs in toll-like receptors and related intracellular signaling molecules and immune responses to measles vaccine: preliminary results. Vaccine 26:1731–1736

    Article  CAS  PubMed  Google Scholar 

  • Jain KK (1998b) Textbook of gene therapy. Hogrefe & Huber, Göttingen-Seattle.

    Google Scholar 

  • Jain KK (2009h) Cell therapy: technologies, markets and companies. Jain PharmaBiotech, Basel, Switzerland.

    Google Scholar 

  • Jain KK (2009i) Gene therapy: technologies, markets and companies. Jain PharmaBiotech, Basel, Switzerland.

    Google Scholar 

  • Jain KK (2009j) RNAi: technologies, markets and companies. Jain PharmaBiotech, Basel, Switzerland.

    Google Scholar 

  • Li Z, Qiao Y, Liu B et al (2005) Combination of imatinib mesylate with autologous leukocyte-derived heat shock protein and chronic myelogenous leukemia. Clin Cancer Res 11:4460–4468

    Article  CAS  PubMed  Google Scholar 

  • Poland GA, Ovsyannikova IG, Jacobson RM (2008) Personalized vaccines: the emerging field of vaccinomics. Expert Opin Biol Ther 8:1659–1667

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kewal K. Jain .

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Jain, K.K. (2009). Personalized Biological Therapies. In: Textbook of Personalized Medicine. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-0769-1_8

Download citation

Publish with us

Policies and ethics